These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 10801796)
1. Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer. Ambrosetti DC; Schöler HR; Dailey L; Basilico C J Biol Chem; 2000 Jul; 275(30):23387-97. PubMed ID: 10801796 [TBL] [Abstract][Full Text] [Related]
2. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Ambrosetti DC; Basilico C; Dailey L Mol Cell Biol; 1997 Nov; 17(11):6321-9. PubMed ID: 9343393 [TBL] [Abstract][Full Text] [Related]
3. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Yuan H; Corbi N; Basilico C; Dailey L Genes Dev; 1995 Nov; 9(21):2635-45. PubMed ID: 7590241 [TBL] [Abstract][Full Text] [Related]
4. The co-activator p300 associates physically with and can mediate the action of the distal enhancer of the FGF-4 gene. Nowling T; Bernadt C; Johnson L; Desler M; Rizzino A J Biol Chem; 2003 Apr; 278(16):13696-705. PubMed ID: 12488456 [TBL] [Abstract][Full Text] [Related]
5. Regulation of the FGF-4 gene by a complex distal enhancer that functions in part as an enhanceosome. Luster TA; Rizzino A Gene; 2003 Dec; 323():163-72. PubMed ID: 14659890 [TBL] [Abstract][Full Text] [Related]
6. Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer. Dailey L; Yuan H; Basilico C Mol Cell Biol; 1994 Dec; 14(12):7758-69. PubMed ID: 7969117 [TBL] [Abstract][Full Text] [Related]
7. Identification of DPPA4 and other genes as putative Sox2:Oct-3/4 target genes using a combination of in silico analysis and transcription-based assays. Chakravarthy H; Boer B; Desler M; Mallanna SK; McKeithan TW; Rizzino A J Cell Physiol; 2008 Sep; 216(3):651-62. PubMed ID: 18366076 [TBL] [Abstract][Full Text] [Related]
8. Spatially precise DNA bending is an essential activity of the sox2 transcription factor. Scaffidi P; Bianchi ME J Biol Chem; 2001 Dec; 276(50):47296-302. PubMed ID: 11584012 [TBL] [Abstract][Full Text] [Related]
9. Molecular basis for synergistic transcriptional activation by Oct1 and Sox2 revealed from the solution structure of the 42-kDa Oct1.Sox2.Hoxb1-DNA ternary transcription factor complex. Williams DC; Cai M; Clore GM J Biol Chem; 2004 Jan; 279(2):1449-57. PubMed ID: 14559893 [TBL] [Abstract][Full Text] [Related]
11. New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2. Botquin V; Hess H; Fuhrmann G; Anastassiadis C; Gross MK; Vriend G; Schöler HR Genes Dev; 1998 Jul; 12(13):2073-90. PubMed ID: 9649510 [TBL] [Abstract][Full Text] [Related]
12. The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2. Nishimoto M; Fukushima A; Okuda A; Muramatsu M Mol Cell Biol; 1999 Aug; 19(8):5453-65. PubMed ID: 10409735 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of regulatory target selection by the SOX high-mobility-group domain proteins as revealed by comparison of SOX1/2/3 and SOX9. Kamachi Y; Cheah KS; Kondoh H Mol Cell Biol; 1999 Jan; 19(1):107-20. PubMed ID: 9858536 [TBL] [Abstract][Full Text] [Related]
14. Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers. Reményi A; Lins K; Nissen LJ; Reinbold R; Schöler HR; Wilmanns M Genes Dev; 2003 Aug; 17(16):2048-59. PubMed ID: 12923055 [TBL] [Abstract][Full Text] [Related]
15. Pax6 and SOX2 form a co-DNA-binding partner complex that regulates initiation of lens development. Kamachi Y; Uchikawa M; Tanouchi A; Sekido R; Kondoh H Genes Dev; 2001 May; 15(10):1272-86. PubMed ID: 11358870 [TBL] [Abstract][Full Text] [Related]
16. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells. Wang P; Branch DR; Bali M; Schultz GA; Goss PE; Jin T Biochem J; 2003 Oct; 375(Pt 1):199-205. PubMed ID: 12841847 [TBL] [Abstract][Full Text] [Related]
17. Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Chew JL; Loh YH; Zhang W; Chen X; Tam WL; Yeap LS; Li P; Ang YS; Lim B; Robson P; Ng HH Mol Cell Biol; 2005 Jul; 25(14):6031-46. PubMed ID: 15988017 [TBL] [Abstract][Full Text] [Related]
18. Distinct roles of SOX2, Pax6 and Maf transcription factors in the regulation of lens-specific delta1-crystallin enhancer. Muta M; Kamachi Y; Yoshimoto A; Higashi Y; Kondoh H Genes Cells; 2002 Aug; 7(8):791-805. PubMed ID: 12167158 [TBL] [Abstract][Full Text] [Related]
19. Differential regulation of the Oct-3/4 gene in cell culture model systems that parallel different stages of mammalian development. Mallanna SK; Boer B; Desler M; Rizzino A Mol Reprod Dev; 2008 Aug; 75(8):1247-57. PubMed ID: 18213644 [TBL] [Abstract][Full Text] [Related]
20. Differential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells. Boer B; Bernadt CT; Desler M; Wilder PJ; Kopp JL; Rizzino A J Cell Physiol; 2006 Jul; 208(1):97-108. PubMed ID: 16523502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]